Ligand Pharmaceuticals Director Unloads: Investor Guide
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
This tag page curates 6 Insider Trading articles that analyze recent share moves, director sales, and investor bets to help you assess risk and make smarter decisions.
364 articlesA director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...
When a company’s CEO purchases thousands of shares, investors sit up and take notice. This article breaks down Brady ...
A large open-market sale by Indivior's Chief Scientific Officer sparked questions about future risk and long-term val...
An Axcelis VP Corporate Controller sold 2,574 shares for roughly $422k. This article breaks down what that means, how...
A single insider purchase can spark questions about a stock, but it isn’t a sure shot signal. This article digs into ...
When a CFO sells company shares worth millions, investors naturally wonder what it means for stock risk and future re...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
An insider sold 50,000 shares of Hinge Health, prompting questions about the stock’s outlook. This guide breaks down ...
When a EZCORP director unloads 10,000 shares, investors naturally wonder if it signals trouble or simply a routine di...
A Sunrun co-founder disclosed the sale of 50,000 shares, prompting questions about timing and implications. This arti...
Samsung Electronics is under a developing insider-trading investigation as regulators scrutinize stock moves tied to ...
When high-level insiders transact, it sparks questions. This article explains what medical's general counsel sells si...